1. In patients with Crohn’s disease (CD) of the pouch following ileal-pouch anal anastomosis (IPAA) for medically-refractory ulcerative colitis (UC),...
1. In patients with metastatic pancreatic cancer, neither modified fluorouracil, leucovorin, irinotecan and oxaliplatin (mFOLFIRINOX) or S-1, irinotecan and oxaliplatin...
1. The Guselkumab group demonstrated significantly greater clinical and endoscopic responses versus placebo. 2. Serious adverse events were comparable, with...
1. The addition of ramucirumab to irinotecan in patients with ramucirumab-refractory advanced or recurrent gastric or gastroesophageal cancer (AGC) did...
1. In a retrospective cohort study of adults included in the National Health and Nutrition Examination Survey (NHANES), obesity was...
1. In this randomized clinical trial, oral vancomycin reduced the risk of recurrent Clostridioides difficile infection (CDI) in participants with...
1. In patients with pouchitis associated with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC), the use of oral...
1. In this randomized controlled trial, patients with resected stage III or high-risk stage II colon cancer who completed adjuvant...
1. In patients with Crohn’s disease (CD), fecal calprotectin (FC) was a useful biomarker for monitoring small bowel lesions and...
1. Time-restricted eating, regardless of timing of the eating window, did not result in significant changes in sleep, mood, or...
